| 股票代码 | 股票名称 | 持有份额(万股) | 仓位比例 | 涨跌 | 贡献增长率 |
| 600976 | 健民集团 | 75.5600 | 8.66% | 0.63% | 0.0546% |
| 688212 | 澳华内镜 | 67.2800 | 8.08% | -0.13% | -0.0105% |
| 600521 | 华海药业 | 278.3300 | 7.12% | 1.33% | 0.0947% |
| 688677 | 海泰新光 | 61.4300 | 6.80% | 2.82% | 0.1918% |
| 603087 | 甘李药业 | 75.7600 | 6.02% | 1.60% | 0.0963% |
| 002675 | 东诚药业 | 209.2500 | 5.67% | 1.22% | 0.0692% |
| 600216 | 浙江医药 | 315.9100 | 5.60% | 0.42% | 0.0235% |
| 300026 | 红日药业 | 578.8800 | 4.49% | -1.07% | -0.0480% |
| 603520 | 司太立 | 187.9100 | 4.49% | 0.17% | 0.0076% |
| 301017 | 漱玉平民 | 157.0700 | 4.14% | 0.32% | 0.0132% |
| 重仓股仓位合计 | 重仓股贡献增长率 | 总持股仓位 | 修正增长率 | ||
| 61.07% | 0.4924% | 93.21% | |||
| 日期 | 实际增长率 | 预估增长率 |
| 2024-04-26 | 0.93% | 0.87% |
| 2024-04-25 | 1.33% | 1.19% |
| 2024-04-24 | 0.63% | 0.59% |
| 2024-04-23 | 1.51% | 1.75% |
| 2024-04-22 | 0.99% | 0.42% |
| 2024-04-19 | -0.51% | -0.75% |
| 2024-04-18 | -0.53% | -0.26% |
| 2024-04-17 | 2.01% | 0.84% |
| 基金名称 | 单位净值 | 日增长率 |
| 长盛城镇化主题混合C | 1.1636 | 6.8442% |
| 华泰柏瑞新经济沪港深混合C | 0.9412 | 6.1020% |
| 德邦鑫星价值C | 1.1751 | 6.0940% |
| 泰达宏利景气智选18个月持有混合A | 1.0058 | 5.9388% |
| 泰达宏利景气智选18个月持有混合C | 0.9995 | 5.9388% |
| 东吴双动力混合C | 0.5411 | 5.9371% |
| 泰达转型C | 2.2886 | 5.9046% |
| 东吴多策略C | 1.8144 | 5.8383% |
| 基金名称 | 单位净值 | 日增长率 |
| 东财数字经济混合发起式A | 0.9766 | 7.1883% |
| 东财数字经济混合发起式C | 0.9599 | 7.1883% |
| 长盛城镇化 | 1.1690 | 6.8442% |
| 长盛城镇化主题混合C | 1.1636 | 6.8442% |
| 华泰柏瑞新经济沪港深混合 | 0.9471 | 6.1020% |
| 华泰柏瑞新经济沪港深混合C | 0.9412 | 6.1020% |
| 德邦鑫星价值 | 1.2206 | 6.0940% |
| 德邦鑫星价值C | 1.1751 | 6.0940% |
